US$ 22.04
retatrutide clinical trials countries Worldwide Strengthening capacity to conduct clinical
Description
reduced atherosclerosis

8.Nauck MA, Quast DR, Wefers J, Pfeiffer AFH

Pathway G - Cardiovascular Protection and Metabolic Health

As mentioned earlier, Wegovy has been FDA-approved, indicating that it has undergone clinical trials to assess its effectiveness, safety, and other relevant factors

Further, a clinical study has demonstrated that the combination of GLP-1R agonist and sodiumglucose cotransporter 2 (SGLT2) inhibitors significantly reduces the risk of all cause-mortality and improves renal function, compared to GLP-1R agonist alone in type 2 diabetic patients [69]
